# Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis

> **NCT01288794** · PHASE4 · COMPLETED · sponsor: **University of Bologna** · enrollment: 431 (actual)

## Conditions studied

- Liver Cirrhosis
- Ascites

## Interventions

- **DRUG:** Diuretics plus human albumin
- **DRUG:** Diuretics (standard medical treatment)

## Key facts

- **NCT ID:** NCT01288794
- **Lead sponsor:** University of Bologna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2014-11
- **Final completion:** 2016-05
- **Target enrollment:** 431 (ACTUAL)
- **Last updated:** 2017-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01288794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01288794, "Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01288794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*